<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="367017">
  <stage>Registered</stage>
  <submitdate>30/08/2014</submitdate>
  <approvaldate>12/09/2014</approvaldate>
  <actrnumber>ACTRN12614000984695</actrnumber>
  <trial_identification>
    <studytitle>System to assist with the diagnosis of suspected lung cancer in patients</studytitle>
    <scientifictitle>A Non-randomized Study to Evaluate the Safety and Performance of the Auris Endoscopy System in patients suspected with lung cancer</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Lung cancer</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Lung - Non small cell</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Lung - Small cell</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The Auris bronchoscopic system guides bronchoscopic tools within the airways to enable biopsy of specimens from suspected malignant lesions using automated mechanical user controls.

The patients will be selected based on the need for a lung biopsy procedure for suspected malignant lesions.  A biopsy procedure will be required for this patient regardless of the technique to be used.  These techniques can vary from a bronchoscopic approach to a transthoracic (through the chest wall) needle approach.

Most often the patient will only need one procedure to evaluate the tissue obtained through the biopsy.</interventions>
    <comparator>There is no control group</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Devices</interventioncode>
    <interventioncode>Diagnosis / Prognosis</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The primary endpoint of the study is the safety profile of the system which will include the incidence of complications and adverse events.  Primary adverse events associated with a bronchoscopic biopsy are pneumothorax and bleeding.  Pneumothorax is when air enters into the thoracic cavity and results in the lung collapsing.  The patient will feel a sense of breathlessness due to the pneumothorax.  Bleeding can be seen during the procedure if it occurs during the bronchoscopic procedure.  Hemoptysis or coughing up blood is another indication of bleeding from the biopsy site.</outcome>
      <timepoint>48 hours post procedure</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>The secondary endpoint is the completion of the intended bronchoscopic procedure and confirmation of correct location via pathology evaluation of resected tissue. </outcome>
      <timepoint>Post procedure pathological evaluation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Subject age above 18 yr of age

Signed informed consent provided

A negative pregnancy test in a woman with child-bearing potential

Lesions in the central airways or peripheral lesions with bronchus sign suspected of malignancy
</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Medical contraindication to bronchoscopy

Participation in any other clinical trial 30 days before and throughout the duration of the study

Uncontrolled or irreversible coagulopathy

Female subjects who are pregnant or nursing or those of child-bearing potential refusing a pregnancy test.

Inability to give consent
</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Safety</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>15/09/2014</anticipatedstartdate>
    <actualstartdate>12/09/2014</actualstartdate>
    <anticipatedenddate />
    <actualenddate>26/09/2014</actualenddate>
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Costa Rica</country>
      <state>San Jose</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Auris, Inc.</primarysponsorname>
    <primarysponsoraddress>125 Shoreway Road, Suite D
San Carlos, CA 94070</primarysponsoraddress>
    <primarysponsorcountry>United States of America</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Auris, Inc.
</fundingname>
      <fundingaddress>125 Shoreway Road, Suite D
San Carlos, CA 94070</fundingaddress>
      <fundingcountry>United States of America</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to evaluate the safety and feasibility of the Auris endoscopy system in diagnostic pulmonary endoscopy. The Auris endoscopy system is a system to guide tools to predetermined points within the airways of the lung in order to extract tissue and specimens for evaluation of suspected malignant lung lesions.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Comite Etico Cientifico Instituto Costarricense de Investigaciones Clinicas [CEC ICIC]</ethicname>
      <ethicaddress>250 metros sur del Gimnasio Nacional, San Jose</ethicaddress>
      <ethicapprovaldate>11/09/2014</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>21/08/2014</ethicsubmitdate>
      <ethiccountry>Costa Rica</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Jose Rafael Rojas</name>
      <address>Hospital Clinica Biblica
Calle Central y Calle 1, Avenida 14
San Jose</address>
      <phone>+506 8413 7098</phone>
      <fax />
      <email>jrrojass@gmail.com </email>
      <country>Costa Rica</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Sam Mostafavi</name>
      <address>125 Shoreway Road, Suite D
San Carlos, CA 94070</address>
      <phone>1 650 209 8698</phone>
      <fax />
      <email>smostafavi@aurisrobotics.com</email>
      <country>United States of America</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Sam Mostafavi</name>
      <address>125 Shoreway Road, Suite D
San Carlos, CA 94070</address>
      <phone>1 650 209 8698</phone>
      <fax />
      <email>smostafavi@aurisrobotics.com</email>
      <country>United States of America</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Sam Mostafavi</name>
      <address>125 Shoreway Road, Suite D
San Carlos, CA 94070</address>
      <phone>1 650 209 8698</phone>
      <fax />
      <email>smostafavi@aurisrobotics.com</email>
      <country>United States of America</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>